Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial

American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement

“…There is a common misperception that BGM is an expensive, complex undertaking with limited benefit, leading some to assert that BGM is not warranted in patients with T2DM (32)(33)(34)(35). The studies that appear to give negative results in patients with T2DM have been criticized for serious experimental design flaws (28).…”

“…Several randomized trials and literature reviews have called into question the clinical utility and cost-effectiveness of routine BGM in patients with T2DM who are not receiving insulin therapy (32,33,35,95,96). A key consideration is that BGM, used alone, does not lower blood glucose levels.…”

Mental distress and health‐related quality of life among type 1 and type 2 diabetes patients using self‐monitoring of blood glucose: A cross‐sectional questionnaire study in Japan

“…Indeed, the present study shows that patients who realize the importance of carrying out SMBG testing are more willing to share SMBG results with their physicians, and that patients realize the importance of carrying out SMBG testing and sharing SMBG results with their physicians more when physicians regularly check patients’ SMBG results to provide meaningful feedback. Previous studies have shown that appropriate SMBG use under instructions from healthcare professionals improved glycemic control and well‐being in type 1 diabetes patients16 and also in non‐insulin treated type 2 diabetes patients17, 18, whereas others have failed to show significant benefits19, 20. As the present study shows that physicians’ regular check of patients’ SMBG results affects patients’ attitude to SMBG use, sharing SMBG results between patients and healthcare professionals could play a critical role in making better use of SMBG to improve glycemic control in type 1 diabetes and type 2 diabetes patients.…”

Blood glucose test strips: options to reduce usage

“…3,4 Several lines of evidence suggest increased discomfort, inconveni ence and worsening of depression scores with regular selfmonitoring, along with a lack of clinically relevant improvement in diabetes-related outcomes in patients who self-test and are not taking insulin. [5][6][7][8][9][10][11][12] Indeed, the Canadian Agency for Drugs and Technologies in Health has recommended against the routine use of blood glucose test strips for most adults with type 2 diabetes using oral hypoglycemic agents.…”